GYY 4137 [Supplementary Concept] has vasodilator, antihypertensive and anti-inflammatory activities; structure in first source Heading Mapped to: Morpholines Organothiophosphorus Compounds
Gyy4137 has been studied across 24 research domains including 🔬 Inflammation, 🔬 Oncology, 🧘 Stress & Anxiety, ❤️ Cardiovascular, 🛡️ Immunity. The primary research focus is 🔬 Inflammation with 29% of studies addressing this area.
This evidence profile for Gyy4137 is generated deterministically from 89 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.